Insights to ligand binding to the monoamine transporters – from homology modeling to LeuBAT and dDAT
Understanding of drug binding to the human biogenic amine transporters is essential to explain the mechanism of action of these pharmaceuticals but more importantly to be able to develop new and improved compounds to be used in the treatment of depression or drug addiction. Until recently no high re...
Main Authors: | Heidi eKoldsø, Julie eGrouleff, Birgit eSchiøtt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00208/full |
Similar Items
-
Monoamine transporters: Insights from molecular dynamics simulations
by: Julie eGrouleff, et al.
Published: (2015-10-01) -
Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function
by: Shreyas Bhat, et al.
Published: (2021-06-01) -
Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
by: Ole Valente Mortensen, et al.
Published: (2015-09-01) -
The use of LeuT as a receptor model for antidepressant development
by: Lina Rustanti
Published: (2012-07-01) -
Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
by: Melodi A. Bowman, et al.
Published: (2020-10-01)